Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with chemotherapy and radiation, with or without surgery, in anaplastic thyroid carcinoma; study completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Thyroid Gland Undifferentiated (Anaplastic) Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28